Amo Lab, founded in 2016, focuses on developing wearable wellness devices incorporating proprietary neuromodulating technology. The company has pioneered a unique treatment protocol for anti-aging, utilizing electromagnetic signals to enhance physiological balance and stimulate the vagus nerve, regulating vagal tone and autonomic nervous system activities. Amofit S, the world's smallest wearable wellness device worn on the neck (41x41x8.9 mm), improves sleep quality, reduces stress and anxiety, and aids in alleviating neurological diseases. The device generates electromagnetic signals to stimulate the vagus nerve in the chest area, thereby regulating vagal tone and autonomic nervous system activity. Its effectiveness has been validated through 3 official clinical trials and 2 academic papers published in international journals. The startup operates within the realms of biotechnology, hardware, health care, life sciences, and medical devices. Amo Lab received a Seed Round investment on 19 September 2018 from Naver D2 Startup Factory.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 1 |
|
19 Sep 2018 |
| Pre Seed Round | Unknown | 1 |
|
15 Jun 2017 |
We care about your data, and we'd love to use cookies make your experience better.
